Tripos Discovery Research Ltd., a Subsidiary of Commonwealth Biotechnologies, Inc., Announces Name Change to Exelgen, Ltd.
RICHMOND, Va. & BUDE, England--(BUSINESS WIRE)--Tripos Discovery Research Limited (TDR), a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ Capital Market: CBTE) and a leading provider of drug discovery chemistry services and small molecule products, announces today that it has changed its name to Exelgen, Ltd.